Effects of Anti-Tumor Necrosis Factor Agents for Familial Mediterranean Fever Patients With Chronic Arthritis and/or Sacroiliitis Who Were Resistant to Colchicine Treatment

APRAŞ BİLGEN Ş. Ş., KILIÇ L., AKDOĞAN A., KİRAZ S., KALYONCU U., KARADAĞ Ö., ...More

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, vol.17, no.7, pp.358-362, 2011 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 17 Issue: 7
  • Publication Date: 2011
  • Doi Number: 10.1097/rhu.0b013e31823682f5
  • Journal Name: JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.358-362
  • Keywords: amyloidosis, anti-tumor necrosis factor agents, chronic arthritis, familial Mediterranean fever, spondyloarthritis, CHIMERIC MONOCLONAL-ANTIBODY, FACTOR-ALPHA INFLIXIMAB, AA AMYLOIDOSIS, NEPHROTIC SYNDROME, DISEASE, SECONDARY, RECEPTOR, SPONDYLOARTHROPATHY, ETANERCEPT, PROTEIN
  • Hacettepe University Affiliated: Yes

Abstract

Background: Effectiveness of anti-tumor necrosis factor (anti-TNF) agents in colchicine-resistant familial Mediterranean fever (FMF) patients has attracted attention in recent years.